Peng Hong, Wang Hong-Bin, Wang Ling, Zhou Bing, Li Xiao-Yong, Tan Jian
Department of Anesthesiology, People's Hospital of Pingxiang City, Jiangxi province, Pingxiang, 337000, P.R. China.
Department of Rehabilitation Medicine, Shangluo Central Hospital, Shangluo, Shaanxi, 726000, P.R. China.
J Integr Neurosci. 2018;17(2):169-175. doi: 10.31083/JIN-170050.
Depression caused by genetic and environmental factors is acomplicated disease. Here, it is demonstrated that glycogen synthase kinase-3β is highly expressed and phosphorylated in the brain of a chronic stress mouse. Inhibition of glycogen synthase kinase-3βleads to decreased depression-like symptoms which manifest in open-field test, tail-suspension test, forced swim test, and a novelty suppressed feeding test. It was also found that β-catenin is attenuated, and its target genes Cyclin D1 and c-Myc are down-regulated. Glycogen synthase kinase-3β was also found to inhibit Erk-Creb-BDNF signaling. These results show that glycogen synthase kinase-3β may promote the progression of depression. Therefore, targeting glycogen synthase kinase-3β may be an effective therapeutic strategy.
由遗传和环境因素引起的抑郁症是一种复杂的疾病。在此研究中发现,糖原合酶激酶-3β在慢性应激小鼠的大脑中高表达且发生磷酸化。抑制糖原合酶激酶-3β会导致抑郁样症状减轻,这在旷场试验、悬尾试验、强迫游泳试验和新奇抑制摄食试验中均有体现。研究还发现β-连环蛋白水平降低,其靶基因细胞周期蛋白D1和c-Myc也下调。此外还发现糖原合酶激酶-3β会抑制Erk-Creb-BDNF信号通路。这些结果表明,糖原合酶激酶-3β可能促进抑郁症的进展。因此,以糖原合酶激酶-3β为靶点可能是一种有效的治疗策略。